Reaction
Blood Immunoglobulin G Increased reporting signals
As of the last recalculation, Blood Immunoglobulin G Increased appears in 1,205 FAERS reports alongside 27 co-occurring drug terms. The strongest observed disproportionality signal is ICOSAPENT ETHYL (PRR 66.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Icosapent Ethyl | 32 | 66.7 | 66.9 |
| Human Immunoglobulin G | 65 | 57.5 | 57.6 |
| Calcium Gluconate | 32 | 47.1 | 47.2 |
| Agalsidase Beta | 21 | 39.9 | 40.0 |
| Desoximetasone | 40 | 37.5 | 37.6 |
| Rosuvastatin Calcium | 46 | 29.3 | 29.3 |
| Moxifloxacin Hydrochloride | 30 | 26.2 | 26.2 |
| Ixazomib | 34 | 21.0 | 21.0 |
| Olmesartan Medoxomil | 41 | 20.4 | 20.4 |
| Rifampicin | 8 | 13.7 | 13.8 |
| Thalidomide | 27 | 13.0 | 13.0 |
| Melphalan Hydrochloride | 18 | 12.6 | 12.6 |
| Melphalan | 14 | 10.7 | 10.8 |
| Insulin Glulisine | 6 | 10.2 | 10.2 |
| Pyrazinamide | 5 | 9.2 | 9.2 |
| Bortezomib | 44 | 8.8 | 8.8 |
| Carfilzomib | 14 | 8.6 | 8.6 |
| Canakinumab | 5 | 8.0 | 8.0 |
| Tiotropium Bromide Inhalation Spray | 5 | 7.7 | 7.7 |
| Nevirapine | 4 | 7.7 | 7.7 |
| Daratumumab | 15 | 6.6 | 6.6 |
| Benralizumab | 7 | 6.1 | 6.1 |
| Lenalidomide | 128 | 5.7 | 5.7 |
| Pomalidomide | 33 | 5.7 | 5.7 |
| Certolizumab Pegol | 35 | 5.3 | 5.3 |
| Romosozumab-Aqqg | 3 | 3.8 | 3.8 |
| Pirfenidone | 7 | 3.0 | 3.0 |